Covered recipient · General Payments record
RAMON ENRIQUE PINO
General Payments · PY2018–2023
$2,903.47
- Reported across 173 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.36 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.23 | 11 |
| Vanda Pharmaceuticals Inc. | $47.68 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.68 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $17.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.33 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142093 | CMS |
| ABBVIE INC. | $15.80 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142097 | CMS |
| ABBVIE INC. | $17.82 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142101 | CMS |
| ABBVIE INC. | $24.69 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142103 | CMS |
| ABBVIE INC. | $20.86 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142107 | CMS |
| ABBVIE INC. | $5.52 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142111 | CMS |
| ABBVIE INC. | $19.59 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142115 | CMS |
| ABBVIE INC. | $8.46 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142119 | CMS |
| ABBVIE INC. | $12.77 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142123 | CMS |
| ABBVIE INC. | $7.96 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142127 | CMS |
| ABBVIE INC. | $28.43 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998142129 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $17.77 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034506225 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.43 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055543143 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.25 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055543149 | CMS |
| Vanda Pharmaceuticals Inc. | $21.67 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051538313 | CMS |
| Vanda Pharmaceuticals Inc. | $26.01 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051538317 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.